Zacks
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
📊
AI Sentiment
Positive
7/10
- Home
- HAE
as of 12-04-2025 3:45pm EST
$84.07
+$2.16
+2.64%
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Chart Type:
Time Range:
| Founded: | 1971 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 3.7B | IPO Year: | 1991 |
| Target Price: | $79.67 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.44 | EPS Growth: | 42.54 |
| 52 Week Low/High: | $47.31 - $85.61 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,327,850,000 | Revenue Growth: | -2.45% |
| Revenue Growth (this year): | -2.19% | Revenue Growth (next year): | 6.01% |
AI-Powered HAE Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 75.00%
75.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Haemonetics Corporation (HAE)
KROLL MARK W
Buy
Director
HAE Nov 10, 2025
Avg Cost/Share
$70.56
Shares
1,400
Total Value
$98,784.00
Owned After
24,757
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| KROLL MARK W | HAE | Director | Nov 10, 2025 | Buy | $70.56 | 1,400 | $98,784.00 | 24,757 |
Latest Haemonetics Corporation News
HAE Breaking Stock News: Dive into HAE Ticker-Specific Updates for Smart Investing
Compare HAE vs Leading Stocks
See how HAE stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HAE Haemonetics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.